Table 2.
Treatment | CAT (U/min) | POD (U/min) | SOD (U/mg protein) | GST (mM/min/mg protein) | GSR (mM//min/mg protein) |
---|---|---|---|---|---|
Control | 3.88 ± 0.53ab | 9.55 ± 0.99ab | 3.00 ± 0.31a | 160.81 ± 8.53a | 224.62 ± 9.02a |
DMSO + Olive oil | 4.19 ± 0.27a | 10.65 ± 1.44ab | 3.07 ± 0.27a | 158.56 ± 11.67a | 220.11 ± 8.01a |
CCl4 | 2.33 ± 0.18†c | 5.31 ± 0.63†c | 1.30 ± 0.23†c | 100.11 ± 4.99†c | 130.52 ± 9.77†d |
CCl4 + silymarin (100 mg/kg) | 3.88 ± 0.28ab | 9.31 ± 0.67ab | 2.93 ± 0.23ab | 151.02 ± 9.49ab | 180.88 ± 9.17†c |
CCl4 + FXM (200 mg/kg) | 2.64 ± 0.15†c | 7.45 ± 0.39†b | 1.58 ± 0.11†c | 133.85 ± 8.34†b | 184.83 ± 8.90†c |
CCl4 + FXM (400 mg/kg) | 3.37 ± 0.24*b | 9.01 ± 0.55ab | 2.46 ± 0.19≠b | 150.70 ± 8.98ab | 198.03 ± 10.64†bc |
FXM (200 mg/kg) | 3.79 ± 0.23ab | 9.44 ± 0.87ab | 2.99 ± 0.18a | 159.57 ± 9.57a | 221.17 ± 7.15a |
FXM (400 mg/kg) | 3.91 ± 0.45ab | 9.59 ± 0.75ab | 2.94 ± 0.20ab | 159.66 ± 9.63a | 216.03 ± 8.42ab |
FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript alphabets indicate significance among treatments (P < 0.01) on not sharing common letter